Wellbutrin is the brand name for bupropion, an atypical antidepressant that works differently from SSRIs and SNRIs. Rather than targeting serotonin, Wellbutrin primarily affects norepinephrine and dopamine — two neurotransmitters involved in motivation, energy, and focus. This unique mechanism makes it a preferred choice for many adults who experience depression alongside fatigue, low motivation, or difficulty concentrating.
The FDA has approved bupropion for major depressive disorder, seasonal affective disorder (marketed as Wellbutrin XL), and smoking cessation (marketed as Zyban). Psychiatrists also prescribe it off-label for ADHD, anxiety, and as an adjunct to other antidepressants when a single medication provides incomplete relief.
Wellbutrin belongs to the norepinephrine-dopamine reuptake inhibitor (NDRI) class. It blocks the reabsorption of norepinephrine and dopamine in the brain, allowing these neurotransmitters to remain active longer in the synaptic space. This dual-action mechanism is what distinguishes bupropion from SSRIs like Lexapro or Prozac, which primarily target serotonin.
Wellbutrin is available in three formulations: immediate-release (IR) taken two to three times daily, sustained-release (SR) taken twice daily, and extended-release (XL) taken once daily. Most psychiatrists prescribe the XL formulation for convenience and more consistent blood levels throughout the day.
Depression is the primary indication for Wellbutrin. It is particularly effective for adults experiencing depression characterized by low energy, hypersomnia, weight gain, and diminished motivation — sometimes called atypical depression features. Because it does not typically cause the sexual side effects or weight gain associated with SSRIs, many patients and psychiatrists prefer it as a first-line or augmentation option.
For seasonal affective disorder, Wellbutrin XL is the only antidepressant with specific FDA approval for prevention. Treatment typically begins in early fall before symptoms develop and continues through winter. Wellbutrin is also commonly added to an SSRI when the SSRI alone does not fully resolve depressive symptoms — a strategy called augmentation that can improve both mood and the sexual side effects that SSRIs sometimes cause.
The most common side effects include dry mouth, nausea, insomnia, headache, dizziness, and constipation. Many of these diminish within the first one to two weeks of treatment. Unlike SSRIs, Wellbutrin rarely causes sexual dysfunction or significant weight gain, which is why many patients who have struggled with those side effects on other medications find bupropion more tolerable.
The most important safety concern with Wellbutrin is a dose-dependent risk of seizures. At standard doses (up to 450 mg/day for XL), the seizure risk is approximately 0.1 percent — comparable to other antidepressants. However, the risk increases significantly at higher doses, which is why there is a strict maximum dosage. Wellbutrin is contraindicated in people with seizure disorders, eating disorders (bulimia and anorexia increase seizure risk), and those undergoing abrupt alcohol or benzodiazepine withdrawal.
Most psychiatrists start Wellbutrin XL at 150 mg once daily for the first week, then increase to 300 mg if tolerated. Some patients notice improvements in energy and motivation within the first week, though the full antidepressant effect typically takes four to six weeks. If 300 mg provides insufficient relief after six to eight weeks, the dose may be increased to 450 mg — the maximum recommended daily dose.
It is important to take Wellbutrin in the morning or early afternoon, as it can cause insomnia when taken too late in the day. The XL tablet should be swallowed whole — crushing or splitting it releases too much medication at once, increasing side effect and seizure risk.
Combining Wellbutrin with alcohol increases the risk of seizures, impairs judgment, and can worsen depression. The prescribing information recommends minimizing or avoiding alcohol use during treatment. Adults who drink heavily should discuss this with their psychiatrist before starting bupropion, as abrupt alcohol cessation in heavy drinkers also raises seizure risk and requires medical supervision.
While Wellbutrin has a lower discontinuation syndrome risk compared to SSRIs, gradual tapering is still recommended. Abruptly stopping can cause irritability, mood changes, and a return of depressive symptoms. Your psychiatrist will typically reduce the dose over one to two weeks. If you experience withdrawal symptoms from other medications, the tapering plan may be adjusted accordingly.
Choosing the right antidepressant requires careful evaluation of your symptoms, medical history, and treatment goals. At Elevate Psychiatry, our board-certified psychiatrists specialize in evidence-based medication management for adults throughout Miami and Florida via telehealth. Whether you are considering starting Wellbutrin, switching from another antidepressant, or looking for augmentation strategies, we provide personalized psychiatric care tailored to your needs.
Schedule an appointment to discuss whether Wellbutrin may be right for you.
When Wellbutrin alone is insufficient for depression, psychiatrists may consider augmentation with medications like Seroquel (quetiapine), which has FDA approval as an adjunctive treatment for major depressive disorder. When burnout crosses the line into clinical depression, Wellbutrin is often preferred because its dopamine and norepinephrine mechanism specifically targets the low motivation, fatigue, and difficulty concentrating that characterize burnout-related depression. For patients who struggle with intense emotions, dialectical behavior therapy (DBT) teaches practical skills for distress tolerance, emotion regulation, and interpersonal effectiveness. For a detailed look at what to expect during treatment, read our complete guide to Wellbutrin side effects — including insomnia, seizure risk, and anxiety considerations.
